Innerer Wert von S&P & Nasdaq Kontaktieren

CalciMedica, Inc. CALC NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
38/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$266.00
+41783.2%

Es gab 50 kürzliche Insider-Transaktionen für CalciMedica, Inc. (CALC), darunter 48 Käufe und 1 Verkauf. Die gesamten Insider-Käufe beliefen sich auf $2.43M und die gesamten Insider-Verkäufe auf $3.65K.

Bedeutende Insider mit kürzlicher Aktivität umfassen Glicklich Alan, Roberts Eric W, Hebbar Sudarshan. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.

Insider-Transaktionen — CALC

Datum Name Funktion Transaktionsart Aktien Ø Preis Wert Gehaltene Aktien
2025-10-13 Glicklich Alan Director RSU-Zuteilung 937 $3.26 $3.05K 937
2025-09-18 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Informierter Kauf 2,500 $3.07 $7.68K 84,150
2025-09-15 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Informierter Kauf 3,400 $2.68 $9.1K 81,650
2025-09-12 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Informierter Kauf 5,000 $3.12 $15.6K 78,250
2025-09-09 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Informierter Kauf 2,343 $3.15 $7.38K 73,250
2025-08-29 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Informierter Kauf 800 $2.74 $2.19K 70,907
2025-08-28 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Informierter Kauf 9,200 $2.86 $26.34K 70,107
2025-08-21 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Informierter Kauf 3,508 $2.79 $9.8K 60,907
2025-08-20 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Informierter Kauf 2,000 $2.72 $5.44K 57,399
2025-08-19 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Informierter Kauf 1,000 $2.79 $2.79K 55,399
2025-08-19 Hebbar Sudarshan Chief Medical Officer Informierter Kauf 9,563 $2.82 $26.96K 61,539
2025-08-15 Hebbar Sudarshan Chief Medical Officer Informierter Kauf 4,392 $2.79 $12.27K 51,976
2025-08-15 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Informierter Kauf 5,076 $2.90 $14.71K 54,399
2025-08-14 Hebbar Sudarshan Chief Medical Officer Informierter Kauf 1,584 $2.59 $4.09K 47,584
2025-07-28 Stauderman Kenneth A. Chief Scientific Officer Informierter Kauf 1,000 $3.96 $3.96K 12,944
2025-07-25 Stauderman Kenneth A. Chief Scientific Officer Informierter Verkauf 1,000 $3.65 $3.65K -
2025-07-22 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Informierter Kauf 1,500 $3.78 $5.66K 49,323
2025-07-21 Leheny A. Rachel 10 Percent Owner, Officer: Chief Executive Officer Informierter Kauf 1,000 $3.40 $3.4K 3,500
2025-07-21 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Informierter Kauf 1,500 $3.37 $5.06K 47,823
2025-07-18 Wilson Robert N Director Informierter Kauf 4,500 $2.87 $12.92K 422,029
2025-07-18 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Informierter Kauf 2,000 $2.88 $5.76K 46,323
2025-07-14 Leheny A. Rachel 10 Percent Owner, Officer: Chief Executive Officer Informierter Kauf 2,500 $2.47 $6.18K 2,500
2025-07-14 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Informierter Kauf 6,500 $2.43 $15.81K 44,323
2025-07-09 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Informierter Kauf 5,000 $1.60 $8.02K 37,823
2025-07-01 Stauderman Kenneth A. Chief Scientific Officer Informierter Kauf 1,000 $1.85 $1.85K 1,000
2025-06-26 Bardin Stephen Chief Financial Officer Informierter Kauf 2,000 $1.50 $3.01K 3,000
2025-06-26 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Informierter Kauf 4,500 $1.44 $6.48K 32,823
2025-06-24 Wilson Robert N Director RSU-Zuteilung 10,000 $1.65 $16.5K 10,000
2025-06-24 Middleton Fred A 10 Percent Owner RSU-Zuteilung 6,562 $1.53 $10.04K 6,562
2025-06-24 Leheny A. Rachel 10 Percent Owner, Officer: Chief Executive Officer RSU-Zuteilung 77,625 $1.53 $118.77K 77,625
2025-06-24 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer RSU-Zuteilung 72,750 $1.53 $111.31K 72,750
2025-06-24 Shaw Allan Director RSU-Zuteilung 8,594 $1.53 $13.15K 8,594
2025-06-24 Glicklich Alan Director RSU-Zuteilung 4,166 $1.53 $6.37K 4,166
2025-06-24 Guerard Frederic Director RSU-Zuteilung 5,000 $1.53 $7.65K 5,000
2025-06-24 Bardin Stephen Chief Financial Officer RSU-Zuteilung 20,000 $1.53 $30.6K 20,000
2025-06-24 Dunn Michael J. President and COO RSU-Zuteilung 47,125 $1.53 $72.1K 47,125
2025-06-24 Hebbar Sudarshan Chief Medical Officer RSU-Zuteilung 83,300 $1.53 $127.45K 83,300
2025-06-24 Stauderman Kenneth A. Chief Scientific Officer RSU-Zuteilung 47,125 $1.53 $72.1K 47,125
2025-06-11 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Informierter Kauf 5,000 $1.85 $9.25K 28,323
2025-06-06 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Informierter Kauf 5,000 $1.78 $8.88K 23,323
2025-06-05 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Informierter Kauf 5,100 $1.70 $8.67K 18,323
2025-05-30 Bardin Stephen Chief Financial Officer Informierter Kauf 1,000 $1.69 $1.69K 41,000
2025-04-23 Leheny A. Rachel 10 Percent Owner, Officer: Chief Executive Officer RSU-Zuteilung 285,000 $1.53 $436.05K 285,000
2025-04-23 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer RSU-Zuteilung 160,000 $1.53 $244.8K 160,000
2025-04-23 Bardin Stephen Chief Financial Officer RSU-Zuteilung 130,000 $1.53 $198.9K 130,000
2025-04-23 Dunn Michael J. President and COO RSU-Zuteilung 125,000 $1.53 $191.25K 125,000
2025-04-23 Hebbar Sudarshan Chief Medical Officer RSU-Zuteilung 175,000 $1.53 $267.75K 175,000
2025-04-23 Stauderman Kenneth A. Chief Scientific Officer RSU-Zuteilung 125,000 $1.53 $191.25K 125,000
2025-01-15 Glicklich Alan Officer Unbekannt - - - -
2025-01-15 Glicklich Alan Director RSU-Zuteilung 20,000 $3.02 $60.4K 20,000
Informativ — Transaktion am offenen Markt (bedeutendste) Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting Neutral — Schenkung, Treuhand, Verfall
Kontaktieren
🎓
SharesGrow Akademie
Lernen Sie inneren Wert zu berechnen und unterbewertete Aktien zu finden.
Wöchentliche Live-Sessions
Nachricht senden